Health and Healthcare Systems
Nature and AI in drug discovery: a solution to high costs
Here's how AI & nature revolutionize drug development, tackling high costs and clinical trial failures to make affordable medicines a reality. Learn more.
Tendai leads Enveda’s sustainability and global health strategic initiatives with national and foreign governments, global environmental organizations and NGOs including the Bill and Melinda Gates Foundation. Previously, Tendai was a biotech investor at Hummingbird Ventures, harboring a high conviction, low frequency investment philosophy deploying checks up to $10M in the next generation of life sciences founders in the US and EU. Tendai holds a PhD in Clinical Biochemistry from the University of Cambridge, England, where she attended with a full scholarship as a Herchel Smith Scholar. She has 10+ years of scientific research experience ranging from infectious disease and obesity to pulmonary disease and schizophrenia, from leading institutes including the Broad Institute of MIT and Harvard and Johns Hopkins Hospital. Outside of work, Tendai enjoys intramural sports, reading foreign fiction and Biblical literature, and helping early stage founders hone their business ideas.
Most Popular